Affimed (AFMD) EBITDA US GAAP (year values)

2021 2021 2022 2022 2023   LTM ? CAGR 5 years ?
EBITDA, ? -64 006 000 -64 006 000 -86 637 000 -81 473 000 -102 380 000   -65 530 000  
Changes by years, y/y, % +87% 0% +35% -6% +26%     +40.2%

Affimed. EBITDA US GAAP, €

Affimed. EBITDA US GAAP, changes, %

Affimed. EBITDA US GAAP, sum by quarters, €

Affimed (AFMD) EBITDA US GAAP (quarter values)

2023Q4 2024Q1 2024Q1 2024Q2 2024Q3   LTM ?
EBITDA, ? -19 317 000 -16 722 000 -17 065 000 -14 702 000 -14 446 000   -65 530 000
Changes by years, y/y, % -31% -49% -39%    
Changes by quarters, q/q, % -18% -13% +2% -14% -2%    

Affimed. EBITDA US GAAP, €

Affimed. EBITDA US GAAP, changes, y/y, %

Affimed. EBITDA US GAAP, changes, q/q, %